However, in a systematic review and meta-analysis of studies examining plasma levels of IL-1β, IL-6, TNFα, and CRP in elderly patients with depression or Alzheimer’s disease, IL-1β was measured in eleven studies between 2005 and 2018 (Ng et al., 2018). This evidence concerns the gene IL1B and depressive symptom measurement.